MIRA
USDMIRA Pharmaceuticals Inc. Common Stock
$1.570-0.120 (-7.101%)
Real-time Price
Healthcare
Drug Manufacturers - General
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$1.690
High
$1.725
Low
$1.560
Volume
0.04M
Company Fundamentals
Market Cap
32.7M
Industry
Drug Manufacturers - General
Country
United States
Trading Stats
Avg Volume
3.18M
Exchange
NCM
Currency
USD
52-Week Range
Low $0.73Current $1.570High $2.45
Related News
AccessWire
MIRA Pharmaceuticals Initiates Multiple Ascending Dose (MAD) Phase 1 Study of Oral Ketamir-2 and Selects Chemotherapy-Induced Neuropathic Pain as Lead Phase 2a Indication
Advancing toward Phase 2a clinical evaluation in chemotherapy-related pain, a condition with no approved treatments and potential for FDA Fast Track consideration MIAMI, FLORIDA / ACCESS Newswire / October 24, 2025 /
View more
Related Stocks
PARA
Paramount Global
NASDAQ
Broadcasting
HTD
John Hancock Tax Advantaged Dividend Income Fund Common Shares of Beneficial Interest
NASDAQ
Finance Compani...
GNT
GAMCO Natural Resources Gold & Income Trust
NASDAQ
Finance/Investo...
WTI
W&T Offshore Inc.
NASDAQ
Oil & Gas Produ...
DTC
Solo Brands Inc.
NASDAQ
Recreational Ga...
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.